Advertisement

Topics

Flex Pharma Picks Interim Executive William McVicar for CEO

17:53 EDT 31 Jul 2017 | Xconomy

Flex Pharma’s (NASDAQ: FLKS) interim CEO, William McVicar, is now officially the company’s top executive. McVicar had been serving as interim CEO of Boston-based Flex since June. He first joined Flex in April as president of research and development. Before joining Flex, McVicar was chief scientific officer of Lexington, MA-based Inotek Pharmaceuticals (NASDAQ: ITEK). Last […]

Original Article: Flex Pharma Picks Interim Executive William McVicar for CEO

NEXT ARTICLE

More From BioPortfolio on "Flex Pharma Picks Interim Executive William McVicar for CEO"

Quick Search
Advertisement